1 Feb 2019 07:00
1 February 2019
AMPHION INNOVATIONS PLC
("Amphion" or "the Company")
Appointment of Joint Broker
The Company is pleased to announce that pursuant to the proposed merger between SP Angel Corporate Finance LLP ("SP Angel") and Northland Capital Partners Ltd, it has appointed SP Angel as its Joint Broker with immediate effect.
For further information please contact:
Amphion Innovations | Tel: +1 (212) 210 6224 | |||
Charlie Morgan |
| |||
Panmure Gordon Limited (Nominated Adviser and Corporate Broker) | Tel: +44 (0)20 7886 2500 | |||
Emma Earl / Freddy Crossley (Corporate Finance) | ||||
Charlie Leigh-Pemberton (Corporate Broking)
| ||||
SP Angel Corporate Finance LLP (Joint Corporate Broker) | Tel: +44 (0) 20 3470 0470 | |||
David Hignell (Corporate Finance) | ||||
Rob Rees (Corporate Broking)
| ||||
Walbrook PR | Tel: +44 (0)20 7933 8780 or amphion@walbrookpr.com | |||
Anna Dunphy / Paul McManus | Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893 | |||
About Amphion Innovations plc - www.amphionplc.com
Amphion Innovations is a developer of medical, life science and technology businesses. We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in a small number of Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies.